Concepedia

Qin Wang

QW

Statistics

Publications

42

Citations

2.1K

H-Index

27

Active since

2002

Affiliations

Harbin Medical University(Current)

Third Affiliated Hospital of Harbin Medical University

Heilongjiang Academy of Sciences

Tianjin Huanhu Hospital

Shanghai Jiao Tong University

Qin Wang is an author at Harbin Medical University specializing in molecular oncology, medicine, and oncology.

ORCID

Publications per year

2002–2025

42

Publications

42

LINC00673 is activated by YY1 and promotes the proliferation of breast cancer cells via the miR-515-5p/MARK4/Hippo signaling pathway

Kun Qiao, Shipeng Ning, Lin Wan et al. · Journal of Experimental & Clinical Cancer Research · 2019 · 210 citations · Full text

, , +17

lncRNA UCA1 Mediates Resistance to Cisplatin by Regulating the miR-143/FOSL2-Signaling Pathway in Ovarian Cancer

Zewu Li, Huanfu Niu, Qianqian Qin et al. · Molecular Therapy — Nucleic Acids · 2019 · 176 citations · Full text

, , +16

Potent, selective, and orally bioavailable matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis

Yonghan Hu, Jason Xiang, Martin J. DiGrandi et al. · Bioorganic & Medicinal Chemistry · 2005 · 108 citations

, , +9

RETRACTED: LncRNA GAS5 suppresses the tumorigenesis of cervical cancer by downregulating miR-196a and miR-205

Wenwu Yang, Hong Li, Xuexian Xu et al. · Tumor Biology · 2017 · 94 citations · Full text

, , +17

miR-106a Increases Granulosa Cell Viability and Is Downregulated in Women With Diminished Ovarian Reserve

Liming Hong, Sha Peng, Ying Li et al. · The Journal of Clinical Endocrinology & Metabolism · 2018 · 83 citations · Full text

, , +15

1–5 of 42